benzothiazide has been researched along with Atrophy in 1 studies
benzothiazide: structure
benzthiazide : 7-Sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by chlorine and that at position 3 is substituted by a benzylsulfanylmethyl group. A diuretic, it is used to treat hypertension and edema.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Takeuchi, A | 1 |
Takahashi, Y | 1 |
Iida, K | 1 |
Hosokawa, M | 1 |
Irie, K | 1 |
Ito, M | 1 |
Brown, JB | 1 |
Ohno, K | 1 |
Nakashima, K | 1 |
Hagiwara, M | 1 |
1 other study available for benzothiazide and Atrophy
Article | Year |
---|---|
Identification of Qk as a Glial Precursor Cell Marker that Governs the Fate Specification of Neural Stem Cells to a Glial Cell Lineage.
Topics: Animals; Astrocytes; Atrophy; Biomarkers; Brain; Cell Differentiation; Cell Lineage; Endocytosis; Mi | 2020 |